Balady Poultry 2024 profit climbs 17% to SAR 118.1M; H2 at SAR 46.2M

03/03/2025 Argaam Exclusive

View other reports

Balady Poultry Trading Co. reported a net profit of SAR 118.1 million in 2024, up 17% from SAR 100.9 million a year earlier.

Financials (M)

Item	2023	2024	Change‬
Revenues	760.97	887.12	16.6 %
Gross Income	118.59	144.45	21.8 %
Operating Income	104.69	121.38	15.9 %
Net Income	100.91	118.11	17.0 %
Average Shares	6.57	6.57	-
Earnings Per Share before unusual items (Riyals)	15.36	17.98	17.0 %
EPS (Riyals)	15.36	17.98	17.0 %

Sales revenue rose 16.58% to approximately SAR 887.11 million in 2024 from SAR 760.97 million in 2023, as average daily production climbed to 192,000 birds per day in 2024 from 164,000 birds in the previous year.

Current Half Annual Comparison (M)

Compared With The

Item	H2 2023	H2 2024	Change‬
Revenues	416.41	437.49	5.1 %
Gross Income	70.03	62.25	(11.1 %)
Operating Income	67.83	53.05	(21.8 %)
Net Income	60.64	46.18	(23.8 %)
Average Shares	6.57	6.57	-
Earnings Per Share before unusual items (Riyals)	9.23	7.03	(23.8 %)
EPS (Riyals)	9.23	7.03	(23.8 %)

Item	H1 2024	H2 2024	Change‬
Revenues	449.63	437.49	(2.7 %)
Gross Income	82.20	62.25	(24.3 %)
Operating Income	68.33	53.05	(22.4 %)
Net Income	71.94	46.18	(35.8 %)
Average Shares	6.57	6.57	-
Earnings Per Share before unusual items (Riyals)	10.95	7.03	(35.8 %)
EPS (Riyals)	10.95	7.03	(35.8 %)

Net earnings for H2 2024 fell 24% to SAR 46.2 million, compared to SAR 60.64 million a year before.

Compared with H1 2024, H2 net earnings declined 35.8% from SAR 71.94 million.

Shareholders’ equity, with no minority interest, stood at SAR 308.94 million at the end of 2024, from SAR 210.22 million a year before.

View more financial results

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

×